Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-1-27
pubmed:abstractText
Dalbavancin, tested against 146 staphylococci, was more potent than other drugs tested, with an MIC at which 50% of staphylococci were inhibited of 0.03 microg/ml and an MIC at which 90% of staphylococci were inhibited of 0.06 microg/ml by microdilution. For all strains, MICs of vancomycin, linezolid, ranbezolid, oritavancin, daptomycin, and quinupristin-dalfopristin were </=4.0 microg/ml. Dalbavancin was bactericidal at four times the MIC against all six strains tested.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-10473224, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-10575140, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-10980159, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-11083648, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-11102412, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-11152434, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-11168143, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-11302827, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-11450881, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-12562720, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-12604559, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-12760876, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-14563898, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-14583862, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-14972384, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-14982811, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-2037793, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-7811020, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-8168564, http://linkedlifedata.com/resource/pubmed/commentcorrection/15673763-9684652
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
770-2
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Antistaphylococcal activity of dalbavancin, an experimental glycopeptide.
pubmed:affiliation
Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't